Status:
TERMINATED
PSIL201 Long-term Follow-up Study: Psilocybin or Niacin / Major Depressive Disorder
Lead Sponsor:
Usona Institute
Conditions:
Major Depressive Disorder
Eligibility:
All Genders
21-65 years
Brief Summary
This is a Phase 2 double-blind, long-term observational follow-up study of participants from Study PSIL201. Participants providing informed consent will be enrolled into this study and will complete w...
Eligibility Criteria
Inclusion
- Enrollment and intervention with the investigational drug in Study PSIL201
Exclusion
- Inability or unwillingness to complete study procedures, including regular completion of web surveys and telephone interviews with study personnel
Key Trial Info
Start Date :
June 30 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 18 2022
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT04353921
Start Date
June 30 2020
End Date
October 18 2022
Last Update
December 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Segal Trials
Lauderhill, Florida, United States, 33319